Iterum Therapeutics plc - Ordinary Share (ITRM): Price and Financial Metrics
ITRM Price/Volume Stats
| Current price | $0.97 | 52-week high | $3.02 |
| Prev. close | $0.95 | 52-week low | $0.81 |
| Day low | $0.95 | Volume | 369,000 |
| Day high | $0.98 | Avg. volume | 480,793 |
| 50-day MA | $1.07 | Dividend yield | N/A |
| 200-day MA | $1.36 | Market Cap | 38.80M |
ITRM Stock Price Chart Interactive Chart >
Iterum Therapeutics plc - Ordinary Share (ITRM) Company Bio
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of adults in uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is based in Dublin, Ireland.
ITRM Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ITRM Price Returns
| 1-mo | -7.62% |
| 3-mo | -29.71% |
| 6-mo | -66.67% |
| 1-year | -29.71% |
| 3-year | -72.60% |
| 5-year | -95.93% |
| YTD | -45.20% |
| 2024 | -10.15% |
| 2023 | 134.52% |
| 2022 | -85.71% |
| 2021 | -60.38% |
| 2020 | -78.02% |